Valuation: Crossject

Market Cap 8.6Cr 10Cr 8.07Cr 7.37Cr 14Cr 955.91Cr 14Cr 96Cr 37Cr 482.25Cr 38Cr 37Cr 1.6TCr P/E 2026 *
3.85x
P/E 2027 * 3.04x
Enterprise Value 6.81Cr 7.94Cr 6.39Cr 5.84Cr 11Cr 757Cr 11Cr 76Cr 29Cr 381.9Cr 30Cr 29Cr 1.26TCr EV / Sales 2026 *
1.12x
EV / Sales 2027 * 0.92x
Free-Float
91.83%
Yield 2026 *
-
Yield 2027 * -
1 day+6.76%
1 week+9.42%
Current month+5.33%
1 month+5.05%
3 months-29.15%
6 months-24.76%
Current year-27.85%
1 week 1.35
Extreme 1.348
1.6
1 month 1.35
Extreme 1.348
1.6
Current year 1.35
Extreme 1.348
2.58
1 year 1.35
Extreme 1.346
2.7
3 years 0.72
Extreme 0.7199
5.96
5 years 0.72
Extreme 0.7199
5.96
10 years 0.72
Extreme 0.7199
8.35
Manager TitleAgeSince
Chief Executive Officer 63 08/08/2001
Director of Finance/CFO - 25/03/2026
Corporate Officer/Principal - 20/08/2024
Director TitleAgeSince
Chairman 67 26/06/2009
Director/Board Member 67 -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
04/07/25 Buy

Director

13,386 0.0266%
01/07/25 Buy

Director

50 0.0001%
01/07/25 Buy

Director

337 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
+6.76%+9.42%+6.04%-60.50% 9.4Cr
+5.66%+19.59%-21.70%-32.63% 13Cr
-2.48%+2.15%+98.90%+54.10% 9.03Cr
+4.93%+13.31%+61.29%-11.83% 6.41Cr
Average +3.72%+10.44%+36.13%-12.72% 9.36Cr
Weighted average by Cap. +3.85%+10.76%+28.55%-15.15%

Financials

2026 *2027 *
Net sales 6.08Cr 7.08Cr 5.71Cr 5.21Cr 9.84Cr 675.64Cr 9.88Cr 68Cr 26Cr 340.85Cr 27Cr 26Cr 1.13TCr 4.23Cr 4.93Cr 3.97Cr 3.63Cr 6.84Cr 470.06Cr 6.88Cr 47Cr 18Cr 237.14Cr 19Cr 18Cr 785.44Cr
Net income 2.83Cr 3.3Cr 2.66Cr 2.43Cr 4.58Cr 314.48Cr 4.6Cr 31Cr 12Cr 158.65Cr 12Cr 12Cr 525.48Cr 77.5L 90.29L 72.74L 66.44L 1.25Cr 86Cr 1.26Cr 8.61Cr 3.34Cr 43Cr 3.39Cr 3.32Cr 143.9Cr
Net Debt -1.79Cr -2.09Cr -1.68Cr -1.53Cr -2.9Cr -198.91Cr -2.91Cr -20Cr -7.71Cr -100.35Cr -7.83Cr -7.66Cr -332.37Cr -4.7Cr -5.48Cr -4.41Cr -4.03Cr -7.6Cr -522.29Cr -7.64Cr -52Cr -20Cr -263.49Cr -21Cr -20Cr -872.71Cr
Logo Crossject
Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Employees
99
Date Price Change Volume
26/26/26 €1.580 +6.76% 6,61,932
25/26/25 €1.480 +3.50% 2,04,084
24/26/24 €1.430 +1.27% 4,63,718
21/26/21 €1.412 -2.22% 2,10,322
20/26/20 €1.444 0.00% 1,68,911
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.580EUR
Average target price
4.400EUR
Spread / Average Target
+178.48%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALCJ Stock